Cargando…

Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma?

SIMPLE SUMMARY: Head and neck cancer is the sixth most common cancer worldwide and typically caused by smoking and alcohol consumption, or infection with Human Papillomavirus (HPV). Currently, treatment options include surgery, radiotherapy, and/or chemotherapy. However, whilst the survival rate in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morgan, Ethan L., Chen, Zhong, Van Waes, Carter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601648/ https://www.ncbi.nlm.nih.gov/pubmed/33036368 http://dx.doi.org/10.3390/cancers12102877

Ejemplares similares

The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2018)

Genomics and advances towards precision medicine for head and neck squamous cell carcinoma
por: Van Waes, Carter, et al.
Publicado: (2017)

Unraveling Regulatory Programs for NF-kappaB, p53 and MicroRNAs in Head and Neck Squamous Cell Carcinoma
por: Yan, Bin, et al.
Publicado: (2013)

TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers
por: Freudlsperger, Christian, et al.
Publicado: (2012)

Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer
por: Li, Zhipeng, et al.
Publicado: (2018)

Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC)
por: Morgan, Ethan L., et al.
Publicado: (2023)

Correlation of NF-κB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma
por: Yan, Ming, et al.
Publicado: (2010)

Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-κB and other signal transcription factors in head and neck squamous cell carcinoma
por: Yan, Bin, et al.
Publicado: (2007)

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
por: Reuter, C W M, et al.
Publicado: (2007)

Systems biology-defined NF-κB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status
por: Yan, Bin, et al.
Publicado: (2008)

Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma
por: Toni, Tiffany, et al.
Publicado: (2023)

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
por: Liu, Shuo, et al.
Publicado: (2022)

Wnt Signaling: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma
por: Javed, Zeeshan, et al.
Publicado: (2019)

CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH‐NF‐κB signalling pathway
por: Qin, Yuexiang, et al.
Publicado: (2019)

Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer
por: Nottingham, Liesl K., et al.
Publicado: (2013)

Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma
por: Wu, Yaping, et al.
Publicado: (2019)

NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)()
por: Almeida, Luciana O., et al.
Publicado: (2013)

Identification of potential therapeutic targets in human head & neck squamous cell carcinoma
por: Han, Jing, et al.
Publicado: (2009)

Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer
por: Yan, Bin, et al.
Publicado: (2013)

Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma
por: Yang, Zejia, et al.
Publicado: (2020)

The Many Roles of Ubiquitin in NF-κB Signaling
por: Courtois, Gilles, et al.
Publicado: (2018)

Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt Signaling
por: Aminuddin, Amnani, et al.
Publicado: (2016)

Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas
por: Sablin, Marie-Paule, et al.
Publicado: (2016)

Potential Therapeutic Significance of Laminin in Head and Neck Squamous Carcinomas
por: Meireles Da Costa, Nathalia, et al.
Publicado: (2021)

CD147 promotes progression of head and neck squamous cell carcinoma via NF‐kappa B signaling
por: Yu, Binbin, et al.
Publicado: (2018)

Demethoxycurcumin induces apoptosis via inhibition of NF-κB pathway in FaDu human head and neck squamous cell carcinoma
por: Lee, Gyeong-Je, et al.
Publicado: (2022)

CD244 represents a new therapeutic target in head and neck squamous cell carcinoma
por: Agresta, Laura, et al.
Publicado: (2020)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
por: Lüttich, Lina, et al.
Publicado: (2021)

NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma
por: Shah, Pooja A., et al.
Publicado: (2020)

Inhibition of transcription factor nuclear factor-κB by a mutant inhibitor-κBα attenuates resistance of human head and neck squamous cell carcinoma to TNF-α caspase-mediated cell death
por: Duffey, D C, et al.
Publicado: (2000)

Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches
por: Allen, Clint T., et al.
Publicado: (2015)

Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review
por: Devaraja, K., et al.
Publicado: (2023)

Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011)

An update on angiogenesis targeting in head and neck squamous cell carcinoma
por: Micaily, Ida, et al.
Publicado: (2020)

Targeted therapy for head and neck squamous cell carcinoma microenvironment
por: Guo, Zhaomeng, et al.
Publicado: (2023)

Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas
por: An, Yi, et al.
Publicado: (2021)

Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2022)

The Role of Ubiquitination in NF-κB Signaling during Virus Infection
por: Song, Kun, et al.
Publicado: (2021)

Identification of potential therapeutic target genes and mechanisms in head and neck squamous cell carcinoma by bioinformatics analysis
por: KUANG, JING, et al.
Publicado: (2016)

X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma
por: Cao, Wei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uohurh5dm4jkj6930aau8sng69